Azalea Vision has enrolled the first patient in its NOA proof-of-concept study, which launches the company’s clinical program. The study evaluates a NOA (Novel Optical Aperture) in a contact lens in two patient groups: keratoconus and presbyopia. The results of the clinical study are expected to provide information for the planned first-in-human evaluation of Azalea’s fully […]